Medtronic to Acquire Intersect ENT for ~$1.1B

August 6, 2021 Auto Bot M&A, MedTech, Medtronic 0

Shots:

  • Medtronic to acquire all outstanding shares of Intersect ENT for $28.25/ share in cash, making a total deal value of ~$1.1B. The transaction is expected to be completed by H1’22
  • The acquisition will expand Medtronic’s product portfolio which is used in the ENT procedure. Additionally, the acquisition will add a bioabsorbable drug release platform to the CRS portfolio
  • Intersect ENT’s PROPEL and SINUVA sinus implants will combine with Medtronic’s navigation, powered instruments, and existing tissue health products to provide solutions for patients suffering from CRS

Click here to­ read full press release/ article | Ref: PR Newswire | Image: Rasayanika

The post Medtronic to Acquire Intersect ENT for ~$1.1B first appeared on PharmaShots.